Deccan Express | An expert panel from Government said no to Pune’s Serum Institute’s Covovax trial on children (Vaccine for children) between age 1 to 17 reports ANI.
According to the report, the Government panel recommends against allowing Serum Institute of India (SII) to conduct phase 2 & 3 clinical trials of Covavax Covid -19 vaccine for children of age 2-17 years and also asked Serum Institute of India to complete trials of Covavax vaccine on adults first.
Government panel recommends against allowing Serum Institute of India to conduct phase 2 & 3 clinical trials of Covavax #COVID19 vaccine on children of age 2-17 years: Sources pic.twitter.com/loOhzpjyFe
— ANI (@ANI) July 1, 2021
SII was preparing to star trials of US firm Novavax’s Indian version of the covid-19 vaccine ‘Covavax’ from July and had planned to start vaccination from September.
The SII also had applied to the Drugs Controller General of India (DCGI) on Monday and sought permission to conduct a trial of Covovax on around 1000 children in 2-17 age groups at 10 sites.
According to report which quotes source mentioned that Subject Expert Committee of the Central Drugs Standard Control Organisation (CDSCO) mentioned that the vaccine has not been approved by any country yet. Hence it recommended that SII should submit the safety data of the Covovax from clinal trials in adults before conducting trials in children.